Specific areas include:
- Studies of the effects of HIV infection and anti-viral HIV therapies on hematopoiesis and the hematopoietic microenvironment.
- Development of novel gene therapy approaches for treating HIV infection based on auto-transplantation of genetically modified hematopoietic stem cells.
- Impact of HIV infection and of anti-viral HIV therapies on immunosuppressive management for hematopoietic stem cell and organ transplantation.
For more information, contact Dr. Daniel Wright, Hematology Program Director, Dr. Laura Moen, Director, Renal and Urology Training Program and Renal Biochemistry Program.
